Matthew Strobeck, a director at QuidelOrtho Corp ($QDEL), made one open market purchase of company shares in the last year, totaling about $240,000. His most recent buy occurred on February 13, 2026. Among nearly 5,000 insiders tracking open market buys, Strobeck's activity ranks 1400th by amount, compared to an average of $1.5 million across 3.3 transactions per insider. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Director | P | Common Stock | 10000 | $23.96 | 82,550.0000 | 68,081,767 | 13.78% | 0.01% |
| Jan. 2, 2026 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Stock Options (Right to Buy) | 6354 | $0.00 | 6,354.0000 | 7,954,541 | 9999.99% | 0.08% |
| Jan. 2, 2026 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Restricted Stock Units | 6804 | $0.00 | 6,804.0000 | 7,954,541 | 9999.99% | 0.09% |
| May 29, 2025 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Director | A | Restricted Stock Units (Equity Grant) | 6829 | $0.00 | 6,829.0000 | 67,446,544 | 9999.99% | 0.01% |
| May 22, 2025 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Director | A | Common Stock | 4929 | $0.00 | 72,550.0000 | 67,446,544 | 7.29% | 0.01% |
| May 22, 2025 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Director | M | Restricted Stock Units (Equity Grant) | 4929 | $0.00 | 0.0000 | 67,446,544 | 100.00% | 0.01% |
| May 20, 2025 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Stock Options (Right to Buy) | 42010 | $0.00 | 42,010.0000 | 145,491,569 | 9999.99% | 0.03% |
| May 20, 2025 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Restricted Stock Units | 80525 | $0.00 | 80,525.0000 | 145,491,569 | 9999.99% | 0.06% |
| Nov. 5, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | P | Common Stock | 4000 | $1.40 | 5,756,157.0000 | 96,235,883 | 0.07% | 0.00% |
| Nov. 5, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | P | Common Stock | 36000 | $1.40 | 5,756,157.0000 | 96,235,883 | 0.63% | 0.04% |
| May 24, 2024 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Not found | M | Restricted Stock Units (Equity Grant) | 2416 | $0.00 | 0.0000 | 66,800,000 | 100.00% | 0.00% |
| May 24, 2024 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Not found | A | Common Stock | 2416 | $0.00 | 67,621.0000 | 66,800,000 | 3.71% | 0.00% |
| May 23, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | M | Series A Non-Voting Convertible Preferred Stock | 1304 | $0.00 | 0.0000 | 96,235,883 | 100.00% | 0.00% |
| May 21, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Stock Options (Right to Buy) | 37050 | $0.00 | 37,050.0000 | 96,235,883 | 9999.99% | 0.04% |
| May 21, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Restricted Stock Units | 53726 | $0.00 | 53,726.0000 | 96,235,883 | 9999.99% | 0.06% |
| May 23, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | M | Common Stock | 295680 | $0.00 | 5,716,157.0000 | 96,235,883 | 5.45% | 0.31% |
| May 23, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | M | Common Stock | 52160 | $0.00 | 5,716,157.0000 | 96,235,883 | 0.92% | 0.05% |
| May 22, 2024 | QuidelOrtho Corp | $QDEL | Strobeck Matthew | Not found | A | Restricted Stock Units (Equity Grant) | 4929 | $0.00 | 4,929.0000 | 66,800,000 | 9999.99% | 0.01% |
| May 23, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | M | Series A Non-Voting Convertible Preferred Stock | 7392 | $0.00 | 0.0000 | 96,235,883 | 100.00% | 0.01% |
| April 5, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Series A Non-Voting Convertible Preferred Stock | 1304 | $46.00 | 8,696.0000 | 96,235,883 | 17.64% | 0.00% |
| April 5, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Series A Non-Voting Convertible Preferred Stock | 7392 | $46.00 | 8,696.0000 | 96,235,883 | 566.87% | 0.01% |
| Jan. 23, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Strobeck Matthew | Director | P | Common Stock | 100000 | $0.00 | 325,238.0000 | 0 | 44.40% | 0.00% |
| Jan. 23, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Strobeck Matthew | Director | P | Common Stock Warrants (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | BIODESIX INC | $BDSX | Strobeck Matthew | Not found | A | Restricted Stock Units | 105389 | $0.00 | 140,036.0000 | 96,235,883 | 304.18% | 0.11% |